Core Insights - The pharmaceutical and biotechnology sector is experiencing increased institutional interest, particularly in brain-computer interface (BCI) stocks, driven by advancements in technology and commercialization efforts [1][2][3] Group 1: Brain-Computer Interface (BCI) Stocks - BCI stocks such as Xiangyu Medical, Aipeng Medical, and Meihao Medical have attracted significant institutional attention, with Xiangyu Medical receiving 208 institutional inquiries, Aipeng Medical 177, and Meihao Medical 125 [1] - Xiangyu Medical plans to upgrade 27 core products by mid-2026 and aims to launch nearly 100 BCI products by the end of 2026, focusing on multi-modal and multi-paradigm applications [2] - Aipeng Medical emphasizes the rapid growth of the BCI industry, particularly in non-invasive applications, and is prioritizing commercialization strategies based on existing technologies and channels [2] - Meihao Medical aims to be a key supplier in the BCI field, enhancing its competitive edge in invasive BCI implants through increased R&D investment and collaboration with clients [2][3] Group 2: Globalization of Pharmaceutical Companies - Domestic pharmaceutical companies are focusing on global strategies, with an emphasis on the commercialization of innovative drugs abroad [4][5] - MediXis has established a 2,000 square meter R&D office in Boston to support its global strategy, with overseas revenue expected to account for approximately 47% of total income by 2025 [4] - Huayuan Pharmaceutical has set up multiple business and R&D centers globally, with overseas revenue reaching 43% of total income in the first half of 2025 [4][5] - The "innovation + internationalization" strategy remains a core focus for the sector, with increasing participation of Chinese companies in global pharmaceutical collaborations [6]

瞧过去，干哩不瓤—— 安阳人常说"干哩不瓤"，这直白的方言，道尽了安阳人"要么不干，要干就干到最好"的实干劲头，是对成绩 最实在的褒奖，更是对实干最生动的诠释。 过去一年的安阳，走得扎实、干得"不瓤"，经济运行稳中向好、趋新向优，全年生产总值增长5.5%，规上工 业增加值增长7.3%。 习近平总书记指出，一个民族需要有民族精神，一个城市同样需要有城市精神。 城市精神是一座城市的灵魂，是城市文化内涵的集中体现，彰显着独有的气质与别样的魅力。城市精神，涌 动在街巷阡陌的烟火肌理间，流淌在朝夕相伴的日常岁月里，更蕴含在带着古音古韵的乡音中。 春日启新程，2月6日，安阳两会如约而至。过去一年的实干答卷，未来一年的发展愿景，皆浓缩于万字的 《政府工作报告》中。这是向全市人民交出的发展答卷，更是对安阳百姓许下的庄严承诺。今时，我们以安 阳人最熟悉的乡音，用"安阳话"解读这份民生承诺，解码这座城市的精神内核与品格底色。 这份成绩，藏在科创的突破里：研发经费投入强度1.86%，技术合同成交额105.27亿元、增长85.5%；蓝天实 验室研发15款警用无人机装备，科创"双中心"促成52项技术合作，83名"科技副总"扎根企业，中 ...

本文核心数据：脑机接口领域细分市场情况;脑机接口领域侵入式脑机接口分析 1、中国脑机接口行业细分市场情况 脑机接口按照信号采集方式可以通常分为侵入式、半侵入式和非侵入式三大类别。目前侵入式脑机接口 的研究主要集中在开发新型材料以及更精细的电极以提高生物相容性，非侵入式产品研究主要集中在改 进材料以提升电极导电率、改进结构以促进电极与皮肤充分接触。较多公司侧重开发非侵入式产品，涉 及教育和泛娱乐、健康和睡眠辅助等。在侵入式领域内深耕的国内公司为数不多，少量公司正在开发无 创或微创的产品与解决方案，以用来进行脑科学研究、精神与心理疾病筛查，各类神经系统疾病监护、 诊疗与康复。 转自：前瞻产业研究院 以下数据及分析来自于前瞻产业研究院脑机接口研究小组发布的《全球及中国脑机接口（BCI）行业发 展前景展望与投资机遇分析报告》。 行业主要上市公司：翔宇医疗(688626)、岩山科技(002195)、科大讯飞(002230)、伟思医疗(688580)、爱 朋医疗(300753)、三博脑科(301293)、创新医疗(002173)等 2、侵入式脑机接口分辨率高 侵入式脑机接口指通过神经外科手术将电极等信号记录装置植入脑内特 ...

Group 1 - Over 800 listed companies have disclosed institutional investor research records since the beginning of the year, with Daikin Heavy Industries being a popular target, attracting over 300 institutions for research [1][3] - In February, Tianneng Wind Power received research attention from over 200 institutions, indicating strong interest in the wind energy sector [1][3] - Daikin Heavy Industries revealed plans for major deliveries of overseas offshore wind monopile projects by 2026, primarily using the DAP delivery model [3] Group 2 - Tianneng Wind Power anticipates accelerated domestic offshore wind bidding and construction from 2025 to 2026, particularly in Guangdong, alongside global demand from Europe, Southeast Asia, Japan, and South Korea, suggesting sustained market growth [3] - Institutional interest is notably high in sectors such as machinery, automotive, and basic chemicals, with significant attention from institutions in the past month [3] - Citic Securities has conducted the most research, exceeding 200 times this year, reflecting a strong interest in A-share listed companies, particularly in bank stocks [3]

2月21日，农历正月初五，省委书记刘宁、省长王凯在郑州与我省民营企业家代表餐叙交流，共贺新 春、共话发展、共谋未来。 河南连续两年举办高规格餐叙，持续释放尊商、重商、安商、富商信号，彰显支持民营经济发展的坚定 决心。 此次参加餐叙交流的企业家代表，来自17家民营企业，涵盖传统制造、新能源、生物医药、人工智能等 多领域，是河南民营经济结构优化、动能转换的生动体现，也折射出河南发展新质生产力的强劲实力。 记者第一时间采访企业家代表，畅谈新春期盼，共抒发展信心。 秦英林 "身近心更近，双向奔赴让企业发展信心更足。" "这两年的交流，让大家感到'身近了，心也更近了'。这种互动是双向奔赴，让企业发展的信心更足、 底气更稳。"牧原实业集团有限公司总裁秦英林表示。 在他看来，从这样的交流中，既能感受到省委、省政府谋长远、顾大局的用心，也彰显了河南企业家踏 实务实、坚韧不拔的企业家精神。 "无论遇到多大困难，我们都不会放弃。"他说，正是凭借这份韧劲攻坚克难，如今众多豫企已成长为行 业标杆，不少跻身中国乃至世界前列。 张传卫 "把老家河南建设成为绿色低碳高质量发展的排头兵。" "回到家乡，倍感亲切，强烈感受到咱们河南老家'一马 ...

正月初五，俗称"破五"，是迎财神的日子。很多经商的人，都习惯在这天开门营业，图个好彩头。这一 天，河南的民营企业家代表，被请到郑州，连续两年在正月初五参加企业家"餐叙"。 去年河南GDP达到6.66万亿元、增长5.6%，增速居全国第3位、经济大省第1位、中部六省第1位，是 2019年以来完成年度目标任务最好的年份，其中民营经济功不可没。最新统计数据显示，河南全省经营 主体1160.5万户，其中95%以上是民营。河南省政府工作报告显示，2025年，河南新增民营经营主体达 370万户。 2025年8月，全国工商联发布的"2025中国民营企业500强"榜单中，河南共有15家企业上榜，洛阳栾川钼 业以约2130亿元的营收总额排名第30位，牧原集团排名第63位，营收总额约为1429亿元。 入围500强的河南企业还有伊电控股集团有限公司（159位）、河南双汇投资发展股份有限公司（204 位）、河南金利金铅集团有限公司（206位）、郑州中瑞实业集团有限公司（232位）、济源市万洋冶炼 （集团）有限公司（254位）、河南豫联能源集团有限责任公司（276位）、郑州宇通企业集团（279 位）、河南龙成集团有限公司（398位）、河 ...

Group 1 - The provincial government emphasizes the importance of private enterprises and entrepreneurs, committing to create a favorable business environment and protect legal rights [2][3] - The government aims to strengthen policy support and optimize services for businesses, focusing on the "two health" practices in Henan [2] - Private entrepreneurs express gratitude for government support and show confidence in the economic development of Henan, pledging to contribute to high-quality growth [3] Group 2 - The meeting highlights the significance of the "14th Five-Year Plan" as a critical phase for the province's development [2] - Entrepreneurs are encouraged to align their business strategies with national and provincial development goals, enhancing the local economy [2] - Various private enterprise leaders participated in the discussion, sharing their commitment to invest in Henan and contribute to its economic progress [3]

Core Insights - The article highlights the increasing focus of institutional investors on hard technology breakthroughs and performance certainty for investment opportunities in 2026 [4] Group 1: Institutional Research Trends - In late 2025 to early 2026, institutions conducted research on approximately 1,162 companies, with a total of 30,000 receptions from listed companies across various core industries [3] - The shift in focus from merely gathering data to understanding practical applications indicates a significant change in investment strategies [9] Group 2: Brain-Computer Interface (BCI) Focus - Brain-computer interface technology has emerged as a key area of interest, with companies like Xiangyu Medical, Aipeng Medical, and Meihao Medical frequently hosting inquiries from fund managers [5][6] - Institutions are particularly interested in the depth of collaboration with innovative BCI clients and the feasibility of mass production [7][8] Group 3: AI Computing Power and Applications - The focus on artificial intelligence has shifted from foundational models to the iteration of computing power and practical applications [10] - Companies like Zhongji Xuchuang attracted attention for their 1.6T optical module orders and technology advancements, reflecting a market shift towards evaluating technological iteration speed [10] Group 4: Commercial Aerospace and Semiconductor Focus - Commercial aerospace has gained significant attention, with institutions exploring various segments such as rocket manufacturing and satellite components [17] - In the semiconductor sector, institutions are focused on overcoming technical barriers, with companies like Haimei Information and Huaren Micro receiving extensive inquiries regarding their advanced process products [22][23] - The trend of institutions closely monitoring companies with promising earnings forecasts indicates a more rational investment approach, seeking high-quality targets with core competitiveness [26]

经济观察网翔宇医疗(688626)2026年有多项已公告或计划中的事件值得关注。 产品研发进展 公司计划在2026年推出数十款脑机接口等新产品，进一步丰富康复医疗设备矩阵，并将脑机接口技术升 级至多模态、多范式体系。 公司业绩目标 脑机接口相关产品预计在2026年对业绩提升起到较大促进作用，目前已在150余家大型医院进行临床使 用与课题合作。 公司项目推进 高管变动 公司控股股东一致行动人安阳启旭贸易咨询服务中心(有限合伙)计划于2026年2月4日至5月3日期间减持 不超过公司总股本3%的股份。 公司目标在2026年将产品覆盖扩展至超1000家三甲医院，目前产品已进入500多家三甲医院。 业务进展情况 公司正积极推进投资并购事宜，以整合行业资源，投融资工作有序进行中。此外，公司牵头申报的河南 省脑机接口康复设备技术创新中心已于2026年1月获批成为省级平台，可能持续推动技术研发。 以上内容基于公开资料整理，不构成投资建议。 ...

智冉医疗解决脑机接口安全性难题，脑机接口作为顶层战略稳步推进 2月9日上午，书记在北京国家信创园考察科技创新工作，接见北京脑科学与类脑研究所的所长罗敏敏等代表。 1月30日，中共中央政治局举行第二十四次集体学习，脑机接口作为"十五五"六大未来产业被重点学习。 我国高通量、可拉伸柔性电极解决行业痛点 北京脑科学与类脑研究所资深研究员、智冉医疗创始人方英领衔的团队，研制 智冉医疗解决脑机接口安全性难题，脑机接口作为顶层战略稳步推进 北京脑科学与类脑研究所资深研究员、智冉医疗创始人方英领衔的团队，研制出一款高通量、可拉伸柔性电极， 该技术解决了传统柔性电极在大脑动态运动时易移位、易脱出的核心问题，为植入式脑机接口长期稳定性提供了 底层解决方案，该成果于2月5日在《NatureElectronics》发表。 国产脑机全链布局，比肩甚至超越Neuralink 马斯克创办的Neuralink公司，首例人体植入术后数周，高达85%的柔性电极丝从该患者的脑组织中脱出。 智冉医疗已拥有电极植入手术机器人及微纳加工车间，可拉伸柔性电极达1024通道，实现从技术路径到工程参 数，比肩甚至超越Neuralink。 受益标的：创新医疗 ...